UCB PHARMA-PROD.FARMACEUTICOS, LDA
Track this competitor Create a free account to be notified when it wins a contract.
- Contracts won
- 1
- Amount won alone
- €315,294 excl. VAT
- Period
- 6 October 2026 – 6 October 2026
Its main clients
- Unidade Local de Saúde Santa Maria, E.P.E. · 1 contract
Where and what
Supplies · 1
Its contracts coming to an end
So many opportunities to take over these contracts when they are re-tendered.
| Planned end | Contract | Current holder | Amount |
|---|---|---|---|
| 5 December 2026 re-tender around October 2026 |
2023/0671 - Certolizumab pegol [200 mg/ 1 ml caneta]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement |
UCB PHARMA-PROD.FARMACEUTICOS, LDA 1 bid received |
€315,294 |
Contracts won
| Date | Contract | Buyer | Amount |
|---|---|---|---|
| 06/10/2026 | 2023/0671 - Certolizumab pegol [200 mg/ 1 ml caneta] | Unidade Local de Saúde Santa Maria, E.P.E. | €315,294 |
Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.